Clinical trial Recruiting at 15 sites Phase 3 Interventional Ages 2 Days to 6

Corticosteroids Before Extubation in Critically Ill Children

Official title: Corticoïdes Avant Extubation en réanimation pédiatrique : étude Multicentrique, Prospective, randomisée, Contre Placebo

Run by Assistance Publique - Hôpitaux de Paris · NCT06722118 · Data updated 2026-11-12

This study tests whether giving dexamethasone before removing a breathing tube helps prevent airway problems in kids who are in the ICU and on a ventilator.

Quick facts

PhasePhase 3
Study typeInterventional
Ages2 Days to 6 Years
SexAll
Enrollment348 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations15 sites (Bordeaux and 14 other locations)
StatusRecruiting
StartedOctober 28, 2025
Main results expectedOctober 2028
Study endsNovember 2028
Registry record updatedAugust 25, 2026
Trial IDNCT06722118 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 2 days to 6 years who have been intubated and on mechanical ventilation for at least 36 hours and are ready for planned extubation.

Probably not a fit

Children with contraindications to IV dexamethasone or those not meeting extubation readiness criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, multicenter, double‑blind study will compare intravenous dexamethasone given before extubation to placebo in children aged 2 days to 6 years who have been on mechanical ventilation for at least 36 hours. The goal is to see if pre‑extubation steroids reduce the incidence of respiratory distress due to upper airway obstruction after extubation. Participating centers include hospitals in Bordeaux, Lyon, and Garches. Key eligibility includes stable oxygenation, PEEP, and airway/cardiovascular status, with parental consent required. Outcomes will inform pediatric extubation practices in PICUs where steroid use is not yet standard.

Why it matters

Potential benefit: If successful, pre‑extubation dexamethasone could lower the risk of post‑extubation respiratory distress and shorten PICU stays for children on ventilators.

How similar studies have gone: Prior adult studies support pre‑extubation steroids for reducing airway obstruction; pediatric data are limited but suggest potential benefit, making this trial novel in children.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients intubated with an endotracheal tube with or without a cuff,
* Aged from 2 days post-term to 6 years,
* On mechanical ventilation for at least 36 hours,

And meeting the following extubation criteria:

* Extubation planned by the medical team
* Fraction of inspired oxygen (FiO2) ≤ 45%,
* Oxygen saturation measured by pulse oximeter ≥ 95% or appropriate according to the pathology,
* Positive end-expiratory pressure (PEEP) ≤ 8 cmH2O,
* Peak inspiratory pressure ≤ 22 cmH2O or presence of cough.
* Affiliated with a social security system,
* Collection of informed consent from the parental authority, by both parents or the legal guardian(s).

Exclusion Criteria:

* Refusal of consent by at least one parent or by the legal guardian(s),
* Patient with a contraindication to IV-DXM:

  * Uncontrolled local or general infection,
  * Active viral infections (hepatitis, herpes, chickenpox, shingles),
  * Live vaccines,
  * Severe coagulation disorders,
  * Ongoing gastrointestinal bleeding,
  * Known hypersensitivity to IV-DXM or one of its excipients.
* Patient participating in another interventional study involving human subjects or being in the exclusion period following a previous study involving human subjects, if applicable,
* Patient receiving State Medical Aid,
* Patient on long-term NIV,
* Known upper airway pathology (UAP) before intubation or at the time of extubation,
* History of UAP surgery within the month preceding inclusion,
* Any situation deemed incompatible with the child's participation in the trial at the discretion of the investigating physician,
* Decision to limit or stop therapeutic interventions.
* Premature patients aged less than 40 weeks of gestation
* Newborns aged less than 2 days after post-term birth

Where it's running

  • CHU Bordeaux - GH Pellegrin
    Bordeaux, France
    Recruiting
  • HFME Lyon-Bron
    Bron, France
    Recruiting
  • Hôpital Raymond Poincaré AP-HP
    Garches, France
    Recruiting
  • Hôpital Bicêtre AP-HP
    Le Kremlin-Bicêtre, France
    Recruiting
  • CHU Lille
    Lille, France
    Recruiting
  • La Timone AP-HM
    Marseille, France
    Recruiting
Show 9 more locations
  • CHRU Nancy
    Nancy, France
    Recruiting
  • Hôpital Necker AP-HP
    Paris, France
    Recruiting
  • Hôpital Necker
    Paris, France
    Recruiting
  • Hôpital Necker
    Paris, France
    Recruiting
  • Hôpital Robert Debré AP-HP
    Paris, France
    Recruiting
  • Hôpital Trousseau AP-HP
    Paris, France
    Recruiting
  • Hôpital Haut-Lévêque CHU Bordeaux
    Pessac, France
    Recruiting
  • CHU Strasbourg Hautepierre
    Strasbourg, France
    Recruiting
  • CHRU de Tours - Hôpital Clocheville
    Tours, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.